The ECA and the PQG Publish Two Draft Chapters on GDP Interpretation

The European Compliance Academy (ECA) and the Pharmaceutical Quality Group (PQG) announce the availability of two draft chapters on the interpretation of the new EU GDP Guideline.

The distribution network for medicinal products is often complex, involving many different parties. In addition to the challenges associated with this complexity, there is also a growing threat from criminal activities seeking to introduce falsified medicines into the legal supply chain. The European regulators recognised several years ago that there was a need to update the content of the 1994 Good Distribution Practice (GDP) guideline to take into account advancements in practices and changes in legislation since it was issued. A consultation draft was issued in mid 2011 and, following the receipt of many comments from interested parties, a final revised version of the GDP Guideline was issued in March 2013 with an effective date of 8 September 2013.

For more information, click here.